Trials / Unknown
UnknownNCT05554185
Probiotic Supplementation During Pregnancy in Preeclampsia High-risk Groups
Effects of Probiotic Supplementation During Pregnancy on Maternal and Infant Outcomes in Preeclampsia High-risk Groups Based on Abnormal Intestinal Flora: a Randomized Controlled Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 338 (estimated)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
In this randomized controlled study, preventive intervention of aspirin combined with probiotics or aspirin combined with placebo would given to PE (pre-eclampsia) high-risk population with gut microbiota dysbiosis during their pregnancy, and finally assess the efficacy and safety of aspirin combined with probiotics to prevent PE.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | aspirin 100mg and probiotics 1 bag | taking aspirin 100mg and probiotics 1 bag per day from 14-16 weeks of pregnancy until 35 + 6 weeks of pregnancy or emergency delivery. |
Timeline
- Start date
- 2022-09-21
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
- First posted
- 2022-09-26
- Last updated
- 2022-09-26
Source: ClinicalTrials.gov record NCT05554185. Inclusion in this directory is not an endorsement.